News • Immunity?
A path to better rabies vaccine design
Scientists shared one of the first high-resolution looks at the rabies virus glycoprotein in its vulnerable 'trimeric' form, revealing potential vaccine targets.
Virus
News • Unifying disease dynamics
Covid-19: New insights into recovery after severe disease
Recovery from severe Covid-19 is characterized by a reduction of certain white blood cells and changes in the molecular regulation of the immune system, an international research team found.
Sponsored • Handheld diagnostics
Veros™ COVID-19 test now available in Europe
Handheld, instrument-free test delivers lab-quality molecular results – 97.9% accuracy – in about 15 minutes, right at the point of care.
News • Protein malformation
Covid-19: immune reaction may cause amyloid generation
In patients with serious and long-term Covid-19, disturbed blood coagulation is often observed. Now, Swedish researchers found a connection between harmful amyloid production and Covid-19 symptoms.
News • Model to predict efficacy
Phage therapy: a viable alternative to antibiotics?
Bacteriophages – viruses that kill bacteria – could be a solution for fighting antibiotic-resistant pathogens, French researchers have developed a model to better predict their efficacy.
News • Viral gateway found
3D analysis gives insights into how Hepatitis enters the liver
Scientists from France and Belgium gained insights into the structure and function of a central liver protein: NTCP, a cellular-entry pathway for bile salts – but also for certain hepatitis viruses.
News • To enter human cells
SARS-CoV-2 hijacks antiviral human proteins
SARS-CoV-2 depends on the broadly antiviral interferon-induced human transmembrane proteins , to enter human cells and replicate inside them.
News • After hospitalization
Covid: two years later, half of patients still have symptoms
Two years after infection with COVID-19, half of patients who were admitted to hospitals still have at least one symptom, according to the longest follow-up study to date.
News • mhealth
Smartphone-powered microchip for at-home diagnostic testing
Researchers developed a new microfluidic chip with broad applications for detecting viruses, pathogens, bacteria and other biomarkers in liquid samples.
News • HHV awaken via microRNA
Why herpes keeps coming back
Dormant herpesviruses induce their reactivation via a previously unknown cellular mechanism mediated by a viral microRNA, Würzburg researchers discovered.
News • UV sterilization
Ultraviolet disinfection against Covid-19: Study gives new insights
UV radiation is one of the go-to methods for preventing the spread of SARS-CoV-2. But what UV dosage kills the virus? What wavelength? How long? A new study answers many of those questions.
News • Coronavirus census
WHO: Covid-19 pandemic claimed almost 15 million lives
In 2020 and 2021, the death toll associated with Covid-19 was approximately 14.9 million, according to the World Health Organization. However, the global distribution has been far from equal.
News • Cognitive impairment after infection
Severe Covid-19 can 'age' our brain by 20 years, study finds
Cognitive impairment as a result of severe Covid-19 is similar to that sustained between 50 and 70 years of age and is the equivalent to losing 10 IQ points, scientists found.
News • Viral aftereffects
Long Covid: Six in ten have at least one symptom one year after infection
Six in ten people with Covid-19 still have at least one symptom a year later, a new study has found. Furthermore, symptoms that don’t clear up after 15 weeks are likely to last at least a year.
Article • UHPLC-MS/MS analysis
Predicting Covid-19 infection severity with mass spec
Using mass spectrometry and chromatography techniques, UK researchers have developed an approach to predict infection severity among Covid-19 patients, as well as potential outcomes.
News • Global study finds increase in deaths
Why is Covid-19 more deadly on weekends?
A global analysis of nearly 6 million Covid-19 deaths finds an increase in mortality at weekends compared to weekdays. Bureaucratic and reporting delays alone do not explain this, researchers report.
News • Effective prevention
Covid-19 vaccination greatly reduces infectious viral load
By comparing the infectious viral load caused by ancestral SARS-CoV-2 as well as by the Delta and Omicron variants, scientists highlight the benefits of vaccination.
News • Mini-livers on a chip
Organoids: step towards hepatitis C vaccine
A platform for studying how the human immune system responds to hepatitis C infection by combining microfluidic technology with liver organoids could speed the hunt for a vaccine.
News • In 2020
COVID-19 restrictions linked to 750,000 fewer dengue cases
COVID-19 measures such as school closures and ‘high-traffic and mixing’ areas had the strongest association, providing clues for new intervention approaches.
News • Adaptable for screening
An optical methodology for rapid detection of COVID-19
The tool has made it possible to detect SARS-CoV-2 in exudate from symptomatic patients with a sensitivity of 100% and a specificity of 87.5%
News • Alternative to injection
Inhaled vaccine delivers broad protection against SARS-CoV-2
Scientists have confirmed that an inhaled form of COVID vaccine can provide broad, long-lasting protection against the original strain of SARS-CoV-2 and variants of concern.
News • COVID and E. coli
Futuristic coating for fabrics kills viruses
Researchers have developed an inexpensive, non-toxic coating for almost any fabric that decreases the infectivity of the virus that causes COVID-19 by up to 90 per cent.
News • Hard to break down
Hepatitis E: Most common hand infectants no match for HEV
Scientists have investigated the effectiveness of various common hand disinfectants against hepatitis E. They were able to show that most formulations do not completely inactivate the virus.
News • Autohaem smear and smear+
Automating blood smears for malaria diagnosis
Researchers have developed a device that removes one of the biggest bottlenecks preventing quick, reliable malaria diagnosis.
News • Multiple sclerosis
Epstein-Barr virus may be leading cause of MS
A connection between the Epstein-Barr virus and multiple sclerosis has long been suspected. A new study provides ‘compelling evidence of causality’.
